Riskpilot← Back to searchSign inGet full accessOscilla A/S
A/SActiveCVR 41833386Åbogade 15Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20208 employees
Revenue 2025
DKK 10M
+39% vs 2024
EBITDA margin
67.8%
+53% vs 2024
Equity ratio
84.3%
Financial strength
Net profit 2025
DKK 5,3M
+53% vs 2024
| Revenue | DKK 10M | +39% |
| EBITDA | DKK 6,8M | +53% |
| Net profit | DKK 5,3M | +53% |
| Total assets | DKK 20M | +30% |
| Equity | DKK 16,8M | +35% |
| Employees | 8 | — |
Legal name
Oscilla A/S
CVR number
41833386
Legal form
Aktieselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
28. oktober 2020
Share capital
DKK 410.000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en direktør.
Company purpose
Virksomhedens formål er udvikling, fremstilling og service af medicinske instrumenter samt anden dermed i forbindelse stående virksomhed efter direktionens skøn
Address
Åbogade 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -43 | 6.784 | 10.317 | 7.167 | 9.983 |
| Staff expenses | -0 | -1.131 | -2.146 | -2.728 | -3.212 |
| EBITDA | -43 | 5.653 | 8.170 | 4.439 | 6.772 |
| Depreciation & amort. | -23 | -43 | -43 | -43 | -43 |
| EBIT | -66 | 5.610 | 8.127 | 4.396 | 6.729 |
| Net financials | -15 | -94 | -29 | 71 | 105 |
| Profit before tax | -81 | 5.516 | 8.099 | 4.467 | 6.834 |
| Tax | -50 | 1.217 | 1.783 | 990 | 1.505 |
| Net profit | -31 | 4.299 | 6.316 | 3.477 | 5.329 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1.557 | 6.201 | 11.722 | 15.407 | 19.970 |
| Equity | 369 | 4.708 | 10.034 | 12.511 | 16.840 |
| Long-term debt | 1.110 | 1.110 | 1.110 | 1.110 | 1.110 |
| Short-term debt | 78 | 374 | 570 | 1.785 | 2.021 |
| Total debt | 1.188 | 1.484 | 1.680 | 2.895 | 3.131 |
EBITDA margin
67.8%
This company
15.8%
Market median
+329% vs market
20212025
Equity ratio
84.3%
This company
38.2%
Market median
+121% vs market
20212025
Return on equity
31.6%
This company
18.4%
Market median
+72% vs market
20212025
Net profit margin
53.4%
This company
8.1%
Market median
+559% vs market
20212025
Asset turnover
0.50×
This company
1.12×
Market median
-55% vs market
20212025
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2020-10-28 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JF Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2021 | |
| Individual | 20–24.99% | 20–24.99% | 2021 | |
| Company | 15–19.99% | 15–19.99% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Oscilla A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Joachim Filtenborg Boll | Chief Executive Officer | 0 companies |
| Ulrik Smed | Board of Directors | 0 companies |
| Tom-Sebastian Voß | Board of Directors | 0 companies |